Lab
Gulf Coast Molecular Laboratories, LLC
Gulf Coast Molecular Laboratories, LLC was paid $1.77M by Medicaid between Mar 2019 and Oct 2023, across 42 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 42% of everything it billed.
33Billing provider infoGULF COAST MOLECULAR LABORATORIES, LLC
SPANISH FORT, AL 36527
SPANISH FORT, AL 36527
33aNPI1780160770assigned 07/13/2018
33bProvider typeClinical Medical Laboratory
28Total paid$1.77M
24GClaims42,773
24DCodes billed42
24AFirst – last monthMar 2019 – Oct 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Alabama
Rank by total paid#18 of 61
Median peer was paid$46K
This provider vs. median39×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 520 | $55K | |
| 2020 | 10,221 | $447K | |
| 2021 | 17,908 | $990K | |
| 2022 | 8,906 | $263K | |
| 2023 | 5,218 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 42% | 3,999 | 3,537 | $745K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 17% | 6,226 | 3,124 | $293K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16% | 5,244 | 4,507 | $285K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 13% | 4,217 | 2,009 | $227K |
| 87581 | 4.8% | 3,535 | 3,058 | $84K | |
| 87486 | 3.3% | 2,352 | 2,143 | $59K | |
| 87481 | <1% | 1,186 | 710 | $13K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 697 | 652 | $11K |
| 87631 | <1% | 153 | 140 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 239 | 208 | $6K |
| 87640 | <1% | 887 | 682 | $5K | |
| 87500 | <1% | 760 | 593 | $5K |
30 more codes
| 87653 | <1% | 866 | $5K | |
| 87511 | <1% | 544 | $4K | |
| 87186 | <1% | 263 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,247 | $3K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | <1% | 2,893 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 1,223 | $2K |
| 87506 | <1% | 14 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 91 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,122 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 27 | $756.00 |
| 87088 | <1% | 253 | $540.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 570 | $462.50 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 658 | $406.70 |
| 36415 | Collection of venous blood by venipuncture | <1% | 947 | $201.61 |
| 83880 | <1% | 90 | $200.61 | |
| 86738 | <1% | 12 | $192.00 | |
| 80074 | <1% | 27 | $90.00 | |
| 80061 | Lipid panel | <1% | 657 | $84.33 |
| 87077 | <1% | 61 | $61.49 | |
| 87081 | <1% | 29 | $32.00 | |
| 82607 | <1% | 315 | $30.92 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 506 | $26.19 |
| 81015 | <1% | 77 | $11.99 | |
| 81003 | <1% | 58 | $11.00 | |
| 81001 | <1% | 229 | $4.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 306 | $0.00 |
| 84439 | 0% | 42 | $0.00 | |
| 83735 | 0% | 39 | $0.00 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 45 | $0.00 |
| 85027 | 0% | 67 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOTTER, JAMES (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| J T Potter JR MD PC | Norton, VA | $1.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.